AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75A50123C00053ATELERIX LIFE SCIENCES INC
Overview
Award facts
- Net obligations
- $68.12K
- $68,115of $68.12K potential value
- Outlays (paid to date)
- $68.12K
- $68.12K paid of $68.12K obligated$68,115
- Period of performance
- Sep 14, 2023 to Jul 23, 2024
- Ended
- Modifications
- 1
- Latest action Jul 23, 2024
- Contract type
- Definitive contract
- PIID 75A50123C00053
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
ATELERIX - THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PLAN AND EXECUTE A PHASE 1A CLINICAL TRIAL (HEREAFTER REFERRED TO AS THE ?PHASE 1A TRIAL?) OF THE NOVEL SMALL MOLECULE ATLX-0199 IN 30 NORMAL HEALTHY SUBJECTS. THE GOAL OF THE CLINICAL TRIAL IS
Dates and value
- Award date
- Signed on Sep 14, 2023
- Potential end of performance
- Jul 22, 2024
- Current value
- $68,115Base and exercised options
- Potential value (if all options are exercised)
- $68,115
Obligations by fiscal year of action
- FY2024: -$680,885 (de-obligation)
- FY2023: $749,000
Total across 2 fiscal years: $68,115
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 23, 2024. View on USAspending · Recipient on SAM.gov
Recipient
LocationCHARLOTTESVILLE, VA
UEITD8NL4UWNVW8
CAGE code8ZNE9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyATELERIX LIFE SCIENCES INC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- OFC ASST SEC FOR PREPARENESS RES
- Funded from
- Public health and social services emergency fundProgram activities075-0140Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Charlottesville, Charlottesville City, Virginia 22902-5662
- Congressional district (place of performance)
- VA-05As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (research and development)
Competition
- Extent competed
- Competed under SAPF
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 100
Solicitation and notices
- Solicitation ID
- EZ-BAA-22-100-SOL-00003(as reported)
- Solicitation date
- Oct 18, 2022
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Atelerix - proof-of-concept clinical trial for a novel respiratory stimulant
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Transaction history
Modification history
- Base award
- Sep 14, 2023Base obligation at award: $749,000
- Latest action
- Jul 23, 2024 — Terminated for convenienceModification P00002; obligation change -$680,885
- Latest substantive action
- Jul 23, 2024 — Terminated for convenienceModification P00002; obligation change -$680,885
- Actions by type
- Base award1
- Terminated for convenience1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- No
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$680,885
- Latest action: change in base and all options
- -$680,885
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- Environmentally preferableF
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A501
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 750501
- Treasury accounts
- 075-2023/2024-0140-000
- Object classes
- 25.1: Advisory and assistance services
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression